Benchmark equity indices surged to fresh record highs amid gains in RIL, Tata Steel and financial stocks on Monday, August 16, 2021. The headline indices, the S&P BSE Sensex and Nifty 50 touched a fresh high of 55,680.75 and 16,589.40 in the intraday trade today. The S&P BSE Sensex closed 145.29 points or 0.26 per cent higher at 55,582.58. Similarly, the Nifty 50 index closed 33.95 points or 0.21 per cent higher at 16,563.05. But certain stocks came in the news after the market was closed. These stocks can impact the indices when it reopens on Tuesday, August 17, 2021. List of such five stocks:

COMMERCIAL BREAK
SCROLL TO CONTINUE READING

See Zee Business Live TV Streaming Below:

Sugar Stocks: Sugar stocks will be in focus today raw sugar price has reached to 4.5 years high due to a fall in supply, which is impacted due to reduced production in Brazil. Besides, the Indian Sugar Mills Association (ISMA) has written to the Prime Minister’s Office (PMO) to immediately increase the Minimum Sale Price (MSP) of sugar from the current Rs 31 per kg to at least Rs 34-35 per kg to help it clear the pending sugarcane dues ahead of the new crushing season that will start from October 2021.

Indiabulls Real Estate: Company has filed the requisite joint application with the jurisdictional bench of NCLT, for its approval to the Scheme of Merger. Earlier, the company received Competition Commission of India’s (CCI’s) approval for a merger of NAM Estates Private Limited (“NAM Estates”) and Embassy One Commercial Property Developments Private Limited (Embassy One”), both Embassy group entities with Indiabulls Real Estate Limited. 

Aarti Industries + Lupin

Aarti Industries: The Board of Directors of the company is scheduled to meet on August 19, 2021, to consider and approve the Scheme of Arrangement ('Demerger') and any other matter incidental thereto.

Lupin: Global pharma major Lupin Limited has received tentative approval from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) Brivaracetam Tablets, 10 mg, 25 mg, 50 mg, 75 mg, and 100 mg, to market a generic equivalent of Briviact® Tablets, 10 mg, 25 mg, 50 mg, 75 mg, and 100 mg, of UCB Inc. This product will be manufactured at Lupin’s Nagpur facility in India. Brivaracetam Tablets are indicated for the treatment of partial-onset seizures in patients four years of age and older. Brivaracetam Tablets (RLD: Briviact® Tablets) had estimated annual sales of USD 311 million in the U.S. (IQVIA MAT June 2021). Besides, Lupin, reportedly, has plans to enter the Chinese market. The company is looking for a manufacturing partner in the Chinese market as it has plans to launch certain respiratory products in the country. 

Delta Corp: The Government of Sikkim has allowed the reopening of the Casinos in the State. The Company and/or its subsidiary operating the Casino in the state of Sikkim will resume its operations from August 16, 2021, and will follow all the safety norms laid down by the state in this regard.

Bulk Deals + Insider Trades

Bulk Deals

Windlas Biotech: ICICI Ltd trading A/C sold 1,22,350 shares at Rs 417.62/share.  
Krsnaa Diagnostics: Birla Sun Life Insurance bought 230,000 shares at Rs 1023.34/share. 
Exxaro Tiles: Morgan Stanley Asia Singapore PTE sold 2,54,380 shares at Rs 127.07/ share. Plutus Wealth Management LLP sold 2,57,235 shares at Rs 127.67/share. 
Spencers Retail: Welspun Multiventures LLP bought 5,21,565 shares at Rs 104.5/share. 

Insider Trades 

Sudarshan Chemical Industries: Promoter Rahul Rathi sold 7.5 lakh shares (1.08%) Via Open Market. Total holding falls from 6.87% to 5.79%.   
Lincoln Pharmaceuticals: Promoters bought 50,000 shares.